相关产品推荐更多 >

EZElisa™大鼠肽YY(PYY)ELISA试剂盒-EZElisa™ Rat Peptide YY (PYY) ELISA Kit
询价
EZElisa™牛钙蛋白酶3(CAPN 3)ELISA试剂盒-EZElisa™ Bovine Calpain 3 (CAPN3) ELISA Kit
询价
EZElisa™人ERBB受体反馈抑制剂1(ERRFI1)ELISA试剂盒-EZElisa™ Human ERBB Receptor feedback Inhibitor 1 (ERRFI1) ELISA Kit
询价
EZElisa™TdT ELISA试剂盒-EZElisa™ TdT ELISA Kit
询价
EZElisa™兔心肌肌钙蛋白I(cTnI)ELISA试剂盒-EZElisa™ Rabbit Cardiac Troponin I (cTnI) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ Lymphocyte Function Associated Antigen 1 Alpha (CD11a) Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™淋巴细胞功能相关抗原1 α(CD11a)试剂盒,EZElisa™ Lymphocyte Function Associated Antigen 1 Alpha (CD11a) Kit,淋巴细胞功能相关抗原1 α(CD11a)试剂盒, Lymphocyte Function Associated Antigen 1 Alpha (CD11a) Kit
产品名称:EZElisa™ Putative T-complex protein 1 subunit theta-like 1(CCT 8L 1 P)试剂盒-EZElisa™ Lymphocyte Function Associated Antigen 1 Alpha (CD11a) Kit
产品货号:A-QEK06461-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of EZElisa™ Lymphocyte Function Associated Antigen 1 Alpha (CD11a) in serum and plasma, tissue homogenates and other biological fluids.
种属:Human
检测方法:比色法
检测范围:0.156 - 10 ng/ml

该EZElisa™淋巴细胞功能相关抗原1 α(CD11a)试剂盒ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™ Putative T-complex protein 1 subunit theta-like 1(CCT 8L 1 P)试剂盒-EZElisa™ Lymphocyte Function Associated Antigen 1 Alpha (CD11a) Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Photolabeling the Transporter Associated with Antigen Processing
in cellular membranes, and the identification of novel peptide-binding proteins (3 -5 ). Crosslinkers function by coupling reactive groups to amino acid side chains of peptides, and are divided into two groups; homobifunctional or heterobifunctional
The Cytotoxic T Lymphocyte Assay for Evaluating Cell-Mediated Immune Function
Evaluation of cell-mediated immunity (CMI) is a significant component in any assessment designed to predict the full range of potential immunotoxic risk underlying health risks. Among measures of CMI, the cytotoxic T Lymphocyte (CTL) response
Antigen Presentation Assays to Investigate Uncharacterized Immunoregulatory Genes
in the antigen presentation process requires a robust, easily manipulated antigen-presenting and T lymphocyte response system. Use of fresh primary antigen-presenting cells (APC) is preferable because cell lines that can present antigen in vitro
技术资料暂无技术资料 索取技术资料




